RIGL

RIGL Earnings Preview

Rigel Pharmaceuticals, Inc. · Healthcare · $554M

14d until earnings

RIGL Earnings

Tuesday, May 05 2026
EPS Estimate
$0.87
$0.57 – $1.10
Revenue Estimate
$64M
Current Price
$31.77

Data Signal Summary

2 bullish
2 bearish
Estimates up +12% Insider selling cluster Put/call 0.3 (bullish skew) Price downtrend

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
-0.9%
P/E Ratio
1.5
Est. Revisions (30d)
+12.5% 0up/1dn
Analyst Target (mean)
$51 $38–$71 +61%
Options P/C Ratio
0.34
Est. Dispersion
60% 3 analysts
Insider Cluster
strong sell
Fund Convergence
strong Renaissance, Citadel, D.E. Shaw, Two Sigma

Recent Activity

insider trades 30 transactions
Sell · RODRIGUEZ RAUL R (Chief Executive Officer) ·9,352 shares ·$200,075
Sell · MOOS WALTER H (Director) ·4,000 shares ·$145,440
Exercise · MOOS WALTER H (Director) ·4,000 shares ·$96,000
Award · RODRIGUEZ RAUL R (Chief Executive Officer) ·53,915 shares
Award · SCHORNO DEAN L (Chief Financial Officer) ·20,636 shares
25 more
Award · FUREY RAYMOND J ·19,497 shr
Award · SANTOS DAVID A ·19,430 shr
Award · ROJKJAER LISA ·18,894 shr
Exercise · RODRIGUEZ RAUL R ·80,000 shr ·$2,192,000
Exercise · SCHORNO DEAN L ·6,500 shr ·$139,786
Award · MOOS WALTER H ·2,500 shr
Award · FROHLICH MARK W ·1,250 shr
Award · LAPOINTE ANTHONY GREGG ·2,500 shr
Award · WASMAN JANE ·2,500 shr
Award · HANNAH ALISON L. ·2,500 shr
Award · ALI-JACKSON KAMIL ·2,500 shr
Sell · SCHORNO DEAN L ·3,770 shr ·$80,615
Sell · FUREY RAYMOND J ·2,787 shr ·$59,653
Sell · SANTOS DAVID A ·3,921 shr ·$83,836
Award · RODRIGUEZ RAUL R ·42,300 shr
Award · SCHORNO DEAN L ·19,717 shr
Award · FUREY RAYMOND J ·19,717 shr
Award · SANTOS DAVID A ·19,717 shr
Exercise · RODRIGUEZ RAUL R ·90,000 shr ·$1,926,000
Other · MOOS WALTER H ·25,000 shr
Other · LAPOINTE ANTHONY GREGG ·25,000 shr
Other · WASMAN JANE ·25,000 shr
Other · HANNAH ALISON L. ·25,000 shr
Other · ALI-JACKSON KAMIL ·25,000 shr
Other · KOTZIN BRIAN L ·25,000 shr